Diabetic gastroparesis: current challenges and future prospects

References

• LacyBECrowellMDMathisCBauerDHeinbergLJGastroparesis: quality of life and health care utilizationJ Clin Gastroenterol2018521202427775961
   PubMed Web of Science ®Google Scholar
• ChoungRSLockeGR3rdSchleckCDZinsmeisterARMeltonLJ3rdTalleyNJRisk of gastroparesis in subjects with type 1 and 2 diabetes in the general populationAm J Gastroenterol20121071828822085818
   PubMed Web of Science ®Google Scholar
• ParkmanHPHallinanEKHaslerWLNausea and vomiting in gastroparesis: similarities and differences in idiopathic and diabetic gastroparesisNeurogastroenterol Motil201628121902191427350152
   PubMed Web of Science ®Google Scholar
• ParkmanHPYatesKHaslerWLSimilarities and differences between diabetic and idiopathic gastroparesisClin Gastroenterol Hepatol201191210561064 quiz e1133–e105421871247
   PubMed Web of Science ®Google Scholar
• RaoSSCamilleriMHaslerWLEvaluation of gastrointestinal transit in clinical practice: position paper of the American and European Neurogastroenterology and Motility SocietiesNeurogastroenterol Motil201123182321138500
   PubMed Web of Science ®Google Scholar
• ParkmanHPHallinanEKHaslerWLEarly satiety and postprandial fullness in gastroparesis correlate with gastroparesis severity, gastric emptying, and water load testingNeurogastroenterol Motil2017294
   Web of Science ®Google Scholar
• KochKLHaslerWLYatesKPBaseline features and differences in 48 week clinical outcomes in patients with gastroparesis and type 1 vs. type 2 diabetesNeurogastroenterol Motil20162871001101526946489
   PubMed Web of Science ®Google Scholar
• HomkoCSirajESParkmanHPThe impact of gastroparesis on diabetes control: patient perceptionsJ Diabetes Complications201630582682927166926
   PubMed Web of Science ®Google Scholar
• BharuchaAEBatey-SchaeferBClearyPADelayed gastric emptying is associated with early and long-term hyperglycemia in type 1 diabetes mellitusGastroenterology2015149233033925980755
   PubMed Web of Science ®Google Scholar
• ShenHLYangSPWangKJEvaluation of gastric blood supply in diabetic patients with gastroparesis by contrast-enhanced ultrasoundBr J Radiol20168910682016036627759430
   PubMed Web of Science ®Google Scholar
• GroverMFarrugiaGLurkenMSCellular changes in diabetic and idiopathic gastroparesisGastroenterology2011140515751585e157821300066
   PubMed Web of Science ®Google Scholar
• IwasakiHKajimuraMOsawaSA deficiency of gastric interstitial cells of Cajal accompanied by decreased expression of neuronal nitric oxide synthase and substance P in patients with type 2 diabetes mellitusJ Gastroenterol200641111076108717160518
   PubMed Web of Science ®Google Scholar
• DeliGBosnyakEPuschGKomolySFeherGDiabetic neuropathies: diagnosis and managementNeuroendocrinology201398426728024458095
   PubMed Web of Science ®Google Scholar
• GroverMBernardCEPasrichaPJClinicalhistological associations in gastroparesis: results from the Gastroparesis Clinical Research ConsortiumNeurogastroenterol Motil2012246531539.e24922339929
   PubMed Web of Science ®Google Scholar
• KashyapPFarrugiaGOxidative stress: key player in gastrointestinal complications of diabetesNeurogastroenterol Motil201123211111421226884
   PubMed Web of Science ®Google Scholar
• NeshatianLGibbonsSJFarrugiaGMacrophages in diabetic gastroparesis–the missing link?Neurogastroenterol Motil201527171825168158
   PubMed Web of Science ®Google Scholar
• BernardCEGibbonsSJMannISAssociation of low numbers of CD206-positive cells with loss of ICC in the gastric body of patients with diabetic gastroparesisNeurogastroenterol Motil20142691275128425041465
   PubMed Web of Science ®Google Scholar
• GroverMBernardCEPasrichaPJDiabetic and idiopathic gastroparesis is associated with loss of CD206-positive macrophages in the gastric antrumNeurogastroenterol Motil2017296
   PubMed Web of Science ®Google Scholar
• HeckertJThomasRMParkmanHPGastric neuromuscular histology in patients with refractory gastroparesis: relationships to etiology, gastric emptying, and response to gastric electric stimulationNeurogastroenterol Motil2017298
   PubMed Web of Science ®Google Scholar
• MohammadMKPepperDJKedarAMeasures of autonomic dysfunction in diabetic and idiopathic gastroparesisGastroenterol Res20169456569
   Google Scholar
• HorvathVJVittalHLorinczAReduced stem cell factor links smooth myopathy and loss of interstitial cells of cajal in murine diabetic gastroparesisGastroenterology2006130375977016530517
   PubMed Web of Science ®Google Scholar
• MearinFCamilleriMMalageladaJRPyloric dysfunction in diabetics with recurrent nausea and vomitingGastroenterology1986906191919253699409
   PubMed Web of Science ®Google Scholar
• MoravejiSBashashatiMElhanafiSDepleted interstitial cells of Cajal and fibrosis in the pylorus: novel features of gastroparesisNeurogastroenterol Motil20162871048105426940535
   PubMed Web of Science ®Google Scholar
• MalikZSankineniAParkmanHPAssessing pyloric sphincter pathophysiology using EndoFLIP in patients with gastroparesisNeurogastroenterol Motil201527452453125712043
   PubMed Web of Science ®Google Scholar
• HaslerWLMayKPWilsonLARelating gastric scintigraphy and symptoms to motility capsule transit and pressure findings in suspected gastroparesisNeurogastroenterol Motil2017302
   Web of Science ®Google Scholar
• MidaniDParkmanHPGranisetron transdermal system for treatment of symptoms of gastroparesis: a prescription registry studyJ Neurogastroenterol Motil201622465065527400689
   PubMed Web of Science ®Google Scholar
• FountoulakisNDunnJThomasSKarallieddeJSuccessful management of refractory diabetic gastroparesis with long-term Aprepitant treatmentDiabet Med201734101483148628636760
   PubMed Web of Science ®Google Scholar
• PasrichaPJYatesKSarosiekIAprepitant for symptoms of gastroparesis and related disorders: the apron randomized clinical trialAm J Gastroenterol2016111S480S48127685301
   PubMed Web of Science ®Google Scholar
• PasrichaPJYatesKPSarosiekIAprepitant has mixed effects on nausea and reduces other symptoms in patients with gastroparesis and related disordersGastroenterology201815416576.e1129111115
   PubMed Web of Science ®Google Scholar
• ClinicalTrials.govStudy to Assess the Efficacy of VLY-686 in Relieving Symptoms of Gastroparesis2017 Available from: https://clinicaltrials.gov/ct2/show/study/NCT02970968Accessed September 16th, 2017
   Google Scholar
• HuilgolVEvansJHellmanRSSoergelKHAcute effect of clonidine on gastric emptying in patients with diabetic gastropathy and controlsAliment Pharmacol Ther200216594595011966503
   PubMed Web of Science ®Google Scholar
• Rosa-e-SilvaLTronconLEOliveiraRBIazigiNGalloLJrFossMCTreatment of diabetic gastroparesis with oral clonidineAliment Pharmacol Ther1995921791837605859
   PubMed Web of Science ®Google Scholar
• ThumshirnMCamilleriMChoiMGZinsmeisterARModulation of gastric sensory and motor functions by nitrergic and alpha2-adrenergic agents in humansGastroenterology1999116357358510029616
   PubMed Web of Science ®Google Scholar
• Danielli MillerNSchiffEBen-AryeEBenefits of acupuncture for diabetic gastroparesis: a comparative preliminary studyAcupunct Med201432213914524323633
   PubMed Web of Science ®Google Scholar
• YangMLiXLiuSMeta-analysis of acupuncture for relieving non-organic dyspeptic symptoms suggestive of diabetic gastroparesisBMC Complement Altern Med20131331124206922
   PubMed Web of Science ®Google Scholar
• SarosiekISongGSunYCentral and peripheral effects of trans-cutaneous acupuncture treatment for nausea in patients with diabetic gastroparesisJ Neurogastroenterol Motil201723224525328163260
   PubMed Web of Science ®Google Scholar
• McCallumRWSoykanISridharKRRicciDALangeRCPlankeyMWDelta-9-tetrahydrocannabinol delays the gastric emptying of solid food in humans: a double-blind, randomized studyAliment Pharmacol Ther19991317780
   PubMed Web of Science ®Google Scholar
• StanghelliniVTalleyNJChanFRome IV–gastroduodenal disordersGastroenterology Epub201621526860903
   PubMed Web of Science ®Google Scholar
• US Food and Drug AdministrationFDA Approved Drug Products1980 Available from: https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&varApplNo=017854Accessed September 16, 2017
   Google Scholar
• Metoclopramide (Reglan)Med Lett Drugs Ther19822461467697087890
   PubMed Web of Science ®Google Scholar
• FoodUSAdministrationDrugFDA Requires Boxed Warning and Risk Mitigation Strategy for Metoclopramide-Containing Drugs2009 Available from: https://www.accessdata.fda.gov/drugsatfda_docs/label/2009/017854s052lbl.pdfAccessed September 16, 2017
   Google Scholar
• EhrenpreisEDDeepakPSifuentesHDeviRDuHLeikinJBThe metoclopramide black box warning for tardive dyskinesia: effect on clinical practice, adverse event reporting, and prescription drug lawsuitsAm J Gastroenterol2013108686687223735907
   PubMed Web of Science ®Google Scholar
• ParkmanHPMishraAJacobsMClinical response and side effects of metoclopramide: associations with clinical, demographic, and pharmacogenetic parametersJ Clin Gastroenterol201246649450322688145
   PubMed Web of Science ®Google Scholar
• ParkmanHPCarlsonMRGonyerDMetoclopramide nasal spray is effective in symptoms of gastroparesis in diabetics compared to conventional oral tabletNeurogastroenterol Motil201426452152824372829
   PubMed Web of Science ®Google Scholar
• McCallumRWFassRBhandariBRCarlsonMRAlvesWSymptom severity influences drug efficacy in women with diabetic gastroparesis: results of a phase 3 study with metoclopramide nasal sprayGastroenterology20171525S1313
   Web of Science ®Google Scholar
• BraunAPDomperidone in the treatment of symptoms of delayed gastric emptying in diabetic patientsAdv Ther1989625162
   Google Scholar
• FranzeseABorrelliOCorradoGDomperidone is more effective than cisapride in children with diabetic gastroparesisAliment Pharmacol Ther200216595195711966504
   PubMed Web of Science ®Google Scholar
• HeckertJParkmanHPTherapeutic response to domperidone in gastroparesis: a prospective study using the GCSI-daily diaryNeurogastroenterol Motil2018301
   Web of Science ®Google Scholar
• HeerMMuller-DuysingWBenesIDiabetic gastroparesis: treatment with domperidone – a double-blind, placebo-controlled trialDigestion19832742142176653921
   PubMed Web of Science ®Google Scholar
• HorowitzMHardingPEChattertonBECollinsPJShearmanDJAcute and chronic effects of domperidone on gastric emptying in diabetic autonomic neuropathyDig Dis Sci1985301193965269
   PubMed Web of Science ®Google Scholar
• KochKLSternRMStewartWRVaseyMWGastric emptying and gastric myoelectrical activity in patients with diabetic gastroparesis: effect of long-term domperidone treatmentAm J Gastroenterol1989849106910752773901
   PubMed Web of Science ®Google Scholar
• KozarekRDomperidone for symptomatic management of diabetic gastroparesis in metoclopramide treatment failuresAdvances in Therapy1990726168
   Google Scholar
• NaglerJMiskovitzPClinical evaluation of domperidone in the treatment of chronic postprandial idiopathic upper gastrointestinal distressAm J Gastroenterol19817664954997036711
   PubMed Web of Science ®Google Scholar
• OrtizACooperCJAlvarezAGomezYSarosiekIMcCallumRWCardiovascular safety profile and clinical experience with high-dose domperidone therapy for nausea and vomitingAm J Med Sci2015349542142425828198
   PubMed Web of Science ®Google Scholar
• PattersonDAbellTRothsteinRKochKBarnettJA double-blind multicenter comparison of domperidone and metoclopramide in the treatment of diabetic patients with symptoms of gastroparesisAm J Gastroenterol19999451230123410235199
   PubMed Web of Science ®Google Scholar
• ScheyRSaadiMMidaniDRobertsACParupalliRPark-manHPDomperidone to treat symptoms of gastroparesis: benefits and side effects from a large single-center cohortDig Dis Sci201661123545355127530760
   PubMed Web of Science ®Google Scholar
• SilversDKipnesMBroadstoneVDomperidone in the management of symptoms of diabetic gastroparesis: efficacy, tolerability, and quality-of-life outcomes in a multicenter controlled trial. DOM-USA-5 Study GroupClin Ther19982034384539663360
   PubMed Web of Science ®Google Scholar
• SoykanISarosiekIMcCallumRWThe effect of chronic oral domperidone therapy on gastrointestinal symptoms, gastric emptying, and quality of life in patients with gastroparesisAm J Gastroenterol19979269769809177513
   PubMed Web of Science ®Google Scholar
• WattsGFArmitageMSinclairJHillRDTreatment of diabetic gastroparesis with oral domperidoneDiabet Med1985264914922951124
   PubMed Web of Science ®Google Scholar
• SugumarASinghAPasrichaPJA systematic review of the efficacy of domperidone for the treatment of diabetic gastroparesisClin Gastroenterol Hepatol20086772673318524689
   PubMed Web of Science ®Google Scholar
• De ColleCvan der HartMChenJRassoulpourAPasrichaPJ1079 NG101: a potent and selective dopamine D2 receptor antagonist as a potential alternative to metoclopramide and domperidone for the treatment of gastroparesisGastroenterology20161504S214
   Web of Science ®Google Scholar
• FarrugiaGMacielagMJPeetersTLSarrMGGaldesASzurszewskiJHMotilin and OHM-11526 activate a calcium current in human and canine jejunal circular smooth muscleAm J Physiol19972732 Pt 1G404G4129277420
   PubMed Web of Science ®Google Scholar
• MagantiKOnyemereKJonesMPOral erythromycin and symptomatic relief of gastroparesis: a systematic reviewAm J Gastroenterol200398225926312591038
   PubMed Web of Science ®Google Scholar
• ParkmanHPPaganoAPVozzelliMARyanJPGastrokinetic effects of erythromycin: myogenic and neurogenic mechanisms of action in rabbit stomachAm J Physiol19952693 Pt 1G418G4267573453
   PubMed Web of Science ®Google Scholar
• RichardsRDDavenportKMcCallumRWThe treatment of idiopathic and diabetic gastroparesis with acute intravenous and chronic oral erythromycinAm J Gastroenterol19938822032078424421
   PubMed Web of Science ®Google Scholar
• TalleyNJVerlindenMGeenenDJEffects of a motilin receptor agonist (ABT-229) on upper gastrointestinal symptoms in type 1 diabetes mellitus: a randomised, double blind, placebo controlled trialGut200149339540111511562
   PubMed Web of Science ®Google Scholar
• DhirRRichterJEErythromycin in the short- and long-term control of dyspepsia symptoms in patients with gastroparesisJ Clin Gastroenterol200438323724215128069
   PubMed Web of Science ®Google Scholar
• ChiniPToskesPPWaseemSHouWMcDonaldRMoshireeBEffect of azithromycin on small bowel motility in patients with gastrointestinal dysmotilityScand J Gastroenterol201247442242722364597
   PubMed Web of Science ®Google Scholar
• MoshireeBMcDonaldRHouWToskesPPComparison of the effect of azithromycin versus erythromycin on antroduodenal pressure profiles of patients with chronic functional gastrointestinal pain and gastroparesisDig Dis Sci201055367568319924535
   PubMed Web of Science ®Google Scholar
• PotterTGSniderKRAzithromycin for the treatment of gastroparesisAnn Pharmacother201347341141523447477
   PubMed Web of Science ®Google Scholar
• JanssenPHarrisMSJonesMThe relation between symptom improvement and gastric emptying in the treatment of diabetic and idiopathic gastroparesisAm J Gastroenterol201310891382139124005344
   PubMed Web of Science ®Google Scholar
• ColldenGTschopMHMullerTDTherapeutic potential of targeting the ghrelin pathwayInt J Mol Sci2017184E79828398233
   PubMed Web of Science ®Google Scholar
• ShinACamilleriMBusciglioIThe ghrelin agonist RM-131 accelerates gastric emptying of solids and reduces symptoms in patients with type 1 diabetes mellitusClin Gastroenterol Hepatol2013111114531459.e5423639598
   PubMed Web of Science ®Google Scholar
• ShinACamilleriMBusciglioIRandomized controlled phase Ib study of ghrelin agonist, RM-131, in type 2 diabetic women with delayed gastric emptying: pharmacokinetics and pharmacodynamicsDiabetes Care2013361414822961573
   PubMed Web of Science ®Google Scholar
• CamilleriMMcCallumRWTackJSpenceSCGottesdienerKFiedorekFTEfficacy and safety of relamorelin in diabetics with symptoms of gastroparesis: a randomized, placebo-controlled studyGastroenterology2017153512401250.e228760384
   PubMed Web of Science ®Google Scholar
• LemboACamilleriMMcCallumRRelamorelin reduces vomiting frequency and severity and accelerates gastric emptying in adults with diabetic gastroparesisGastroenterology201615118796.e627055601
   PubMed Web of Science ®Google Scholar
• BourasEPCamilleriMBurtonDDMcKinzieSSelective stimulation of colonic transit by the benzofuran 5HT4 agonist, prucalopride, in healthy humansGut199944568268610205205
   PubMed Web of Science ®Google Scholar
• De SchryverAMAndriesseGISamsomMSmoutAJGooszenHGAkkermansLMThe effects of the specific 5HT(4) receptor agonist, prucalopride, on colonic motility in healthy volunteersAliment Pharmacol Ther200216360361211876716
   PubMed Web of Science ®Google Scholar
• KessingBFSmoutAJBenninkRJKraaijpoelNOorsJMBrede-noordAJPrucalopride decreases esophageal acid exposure and accelerates gastric emptying in healthy subjectsNeurogastroenterol Motil20142681079108624891067
   PubMed Web of Science ®Google Scholar
• BradenBEnghoferMSchaubMUsadelKHCasparyWFLembckeBLong-term cisapride treatment improves diabetic gastroparesis but not glycaemic controlAliment Pharmacol Ther20021671341134612144585
   PubMed Web of Science ®Google Scholar
• DegenLPetrigCStuderDSchrollerSBeglingerCEffect of tegaserod on gut transit in male and female subjectsNeurogastroenterol Motil200517682182616336497
   PubMed Web of Science ®Google Scholar
• TackJCamilleriMChangLSystematic review: cardiovascular safety profile of 5-HT(4) agonists developed for gastrointestinal disordersAliment Pharmacol Ther201235774576722356640
   PubMed Web of Science ®Google Scholar
• CarboneFRotondoAAndrewsCOP054-LB1A controlled cross-over trial shows benefit of prucalopride for symptom control and gastric emptying in gastroparesisUEG Suppl Abstracts201536561571
   Google Scholar
• AhnABarnesCShaywitzDGrimaldiMCanafaxDMVelusetrag improves gastric emptying time in subjects with diabetic or idiopathic gastroparesisGastroenterology20151484S507
   Web of Science ®Google Scholar
• SmithJABeattieDTMarquessDShawJPVickeryRGHumphreyPPThe in vitro pharmacological profile of TD-5108, a selective 5-HT(4) receptor agonist with high intrinsic activityNaunyn Schmiedebergs Arch Pharmacol2008378112513718415081
   PubMed Web of Science ®Google Scholar
• EisenmanSTGibbonsSJVerhulstPJCiprianiGSaurDFarrugiaGTumor necrosis factor alpha derived from classically activated “M1”macrophages reduces interstitial cell of Cajal numbersNeurogastroenterol Motil2017294
   Web of Science ®Google Scholar
• BharuchaAEDaleySLLowPAEffects of hemin on heme oxygenase-1, gastric emptying, and symptoms in diabetic gastroparesisNeurogastroenterol Motil201628111731174027283929
   PubMed Web of Science ®Google Scholar
• LeelakanokNHolcombeASchweizerMLDomperidone and risk of ventricular arrhythmia and cardiac death: a systematic review and meta-analysisClin Drug Investig201636297107
   Web of Science ®Google Scholar
• BaguleyWAHayWTMackieKPCheneyFWCullenBFCardiac dysrhythmias associated with the intravenous administration of ondansetron and metoclopramideAnesth Analg1997846138013819174325
   PubMed Web of Science ®Google Scholar
• DigbyGMachaalanyJMalikPMultifactorial QT interval prolongationCardiol J201017218418820544619
   PubMed Web of Science ®Google Scholar
• DigbyGCPerez RieraARBarbosa BarrosRAcquired long QT interval: a case series of multifactorial QT prolongationClin Cardiol201134957758221887689
   PubMed Web of Science ®Google Scholar
• HaslerWLParkmanHPWilsonLAPsychological dysfunction is associated with symptom severity but not disease etiology or degree of gastric retention in patients with gastroparesisAm J Gastroenterol2010105112357236720588262
   PubMed Web of Science ®Google Scholar
• YoussefASParkmanHPNagarSDrug-drug interactions in pharmacologic management of gastroparesisNeurogastroenterol Motil201527111528154126059917
   PubMed Web of Science ®Google Scholar
• StoetzerCVoelkerMDollTHeinekeJWegnerFLefflerACardiotoxic antiemetics metoclopramide and domperidone block cardiac voltage-gated Na+ channelsAnesth Analg20171241526027861438
   PubMed Web of Science ®Google Scholar
• RossiMGiorgiGDomperidone and long QT syndromeCurr Drug Saf20105325726220394569
   PubMedGoogle Scholar
• BashashatiMSarosiekISiddiquiTMcCallumRWAdverse effects of domperidone: prolonged QuesT for knowledge?Dig Dis Sci201661123384338627714509
   PubMed Web of Science ®Google Scholar
• HallandMBharuchaAERelationship between control of glycemia and gastric emptying disturbances in diabetes mellitusClin Gastroenterol Hepatol201614792993626717862
   PubMed Web of Science ®Google Scholar
• JonesKLRussoABerryMKStevensJEWishartJMHorowitzMA longitudinal study of gastric emptying and upper gastrointestinal symptoms in patients with diabetes mellitusAm J Med2002113644945512427492
   PubMed Web of Science ®Google Scholar
• HaslerWLSoudahHCDulaiGOwyangCMediation of hyperglycemia-evoked gastric slow-wave dysrhythmias by endogenous prostaglandinsGastroenterology199510837277367875475
   PubMed Web of Science ®Google Scholar
• SamsomMAkkermansLMJebbinkRJvan IsseltHvanBerge-HenegouwenGPSmoutAJGastrointestinal motor mechanisms in hyperglycaemia induced delayed gastric emptying in type I diabetes mellitusGut19974056416469203944
   PubMed Web of Science ®Google Scholar
• Oster-JorgensenEQvistNPedersenSARasmussenLHovendalCPThe influence of induced hyperglycaemia on the characteristics of intestinal motility and bile kinetics in healthy menScand J Gastroenterol19922742852881589706
   PubMed Web of Science ®Google Scholar
• HorowitzMJonesKLRaynerCKReadNW‘Gastric’ hypoglycaemia – an important concept in diabetes managementNeurogastroenterol Motil200618640540716700718
   PubMed Web of Science ®Google Scholar
• LysyJIsraeliEStrauss-LiviatanNGoldinERelationships between hypoglycaemia and gastric emptying abnormalities in insulin-treated diabetic patientsNeurogastroenterol Motil200618643344016700722
   PubMed Web of Science ®Google Scholar
• HyettBMartinezFJGillBMDelayed radionucleotide gastric emptying studies predict morbidity in diabetics with symptoms of gastroparesisGastroenterology2009137244545219410575
   PubMed Web of Science ®Google Scholar
• ChangJRaynerCKJonesKLHorowitzMPrognosis of diabetic gastroparesis – a 25-year evaluationDiabet Med2013305e185e18823350946
   PubMed Web of Science ®Google Scholar
• OlaussonEAStorsrudSGrundinHIsakssonMAttvallSSimrenMA small particle size diet reduces upper gastrointestinal symptoms in patients with diabetic gastroparesis: a randomized controlled trialAm J Gastroenterol2014109337538524419482
   PubMed Web of Science ®Google Scholar
• HomkoCJDuffyFFriedenbergFKBodenGParkmanHPEffect of dietary fat and food consistency on gastroparesis symptoms in patients with gastroparesisNeurogastroenterol Motil201527450150825600163
   PubMed Web of Science ®Google Scholar
• YuKKeMYLiWHZhangSQFangXCThe impact of soluble dietary fibre on gastric emptying, postprandial blood glucose and insulin in patients with type 2 diabetesAsia Pac J Clin Nutr201423221021824901089
   PubMed Web of Science ®Google Scholar
• PouderouxPFriedmanNShiraziPRingelsteinJGKeshavarzianAEffect of carbonated water on gastric emptying and intragastric meal distributionDig Dis Sci199742134399009113
   PubMed Web of Science ®Google Scholar
• ParkmanHPYatesKPHaslerWLDietary intake and nutritional deficiencies in patients with diabetic or idiopathic gastroparesisGastroenterology20111412486498498e1e721684286
   PubMed Web of Science ®Google Scholar
• CamilleriMParkmanHPShafiMAAbellTLGersonLAmerican College of GastroenterologyClinical guideline: management of gastroparesisAm J Gastroenterol201310811837 quiz 3823147521
   PubMed Web of Science ®Google Scholar
• FontanaRJBarnettJLJejunostomy tube placement in refractory diabetic gastroparesis: a retrospective reviewAm J Gastroenterol19969110217421788855743
   PubMed Web of Science ®Google Scholar
• MapleJTPetersenBTBaronTHGostoutCJWong Kee SongLMButtarNSDirect percutaneous endoscopic jejunostomy: outcomes in 307 consecutive attemptsAm J Gastroenterol2005100122681268816393220
   PubMed Web of Science ®Google Scholar
• FanACBaronTHRumallaAHarewoodGCComparison of direct percutaneous endoscopic jejunostomy and PEG with jejunal extensionGastrointest Endosc200256689089412447304
   PubMed Web of Science ®Google Scholar
• UdorahMOFleischmanMWBalaVCaiQEndoscopic clips prevent displacement of intestinal feeding tubes: a long-term follow-up studyDig Dis Sci201055237137419242799
   PubMed Web of Science ®Google Scholar
• SamarasenaJBKwakNHChangKJLeeJGThe PEG-Pedi-PEG technique: a novel method for percutaneous endoscopic gastrojejunostomy tube placement (with video)Gastrointest Endosc20168461030103327329090
   PubMed Web of Science ®Google Scholar
• TeiglandTIversenMMSangnesDADimcevskiGSoftelandEA longitudinal study on patients with diabetes and symptoms of gastroparesis – associations with impaired quality of life and increased depressive and anxiety symptomsJ Diabetes Complications2018321899429153755
   PubMed Web of Science ®Google Scholar
• PasrichaPJYatesKPNguyenLOutcomes and factors associated with reduced symptoms in patients with gastroparesisGastroenterology2015149717621774.e426299414
   PubMed Web of Science ®Google Scholar
• CherianDSachdevaPFisherRSParkmanHPAbdominal pain is a frequent symptom of gastroparesisClin Gastroenterol Hepatol20108867668120472097
   PubMed Web of Science ®Google Scholar
• HaslerWLWilsonLAParkmanHPFactors related to abdominal pain in gastroparesis: contrast to patients with predominant nausea and vomitingNeurogastroenterol Motil2013255427438e300e30123414452
   PubMed Web of Science ®Google Scholar
• HoogerwerfWAPasrichaPJKallooANSchusterMMPain: the overlooked symptom in gastroparesisAm J Gastroenterol19999441029103310201478
   PubMed Web of Science ®Google Scholar
• BoelensOBScheltingaMRHoutermanSRoumenRMRandomized clinical trial of trigger point infiltration with lidocaine to diagnose anterior cutaneous nerve entrapment syndromeBr J Surg2013100221722123180371
   PubMed Web of Science ®Google Scholar
• JehangirAParkmanHPChronic opioids in gastroparesis: relationship with gastrointestinal symptoms, healthcare utilization and employmentWorld J Gastroenterol201723407310732029142478
   PubMed Web of Science ®Google Scholar
• SzigethyEKniselyMDrossmanDOpioid misuse in gastroenterology and non-opioid management of abdominal painNat Rev Gastroenterol Hepatol201815316818029139482
   PubMed Web of Science ®Google Scholar
• JeongIDCamilleriMShinAA randomised, placebo-controlled trial comparing the effects of tapentadol and oxycodone on gastrointestinal and colonic transit in healthy humansAliment Pharmacol Ther20123591088109622348605
   PubMed Web of Science ®Google Scholar
• UklejaATandonKShahKAlvarezAEndoscopic botox injections in therapy of refractory gastroparesisWorld J Gastrointest Endosc20157879079826191343
   PubMed Web of Science ®Google Scholar
• YinGTanWHuDEndoscopic ultrasonography-guided intrapyloric injection of botulinum toxin to treat diabetic gastroparesisDig Endosc201628775927556873
   PubMed Web of Science ®Google Scholar
• GuoHFangCHuangYTreatment of diabetic gastroparesis with botulinum toxin injection guided by endoscopic ultrasound in a patient with type 1 diabetes: the first reportActa Diabetol201754550951127696071
   PubMed Web of Science ®Google Scholar
• KhashabMABesharatiSNgamruengphongSRefractory gastroparesis can be successfully managed with endoscopic transpyloric stent placement and fixation (with video)Gastrointest Endosc20158261106110926253017
   PubMed Web of Science ®Google Scholar
• MarankiJLLytesVMeilahnJEPredictive factors for clinical improvement with Enterra gastric electric stimulation treatment for refractory gastroparesisDig Dis Sci20085382072207818080765
   PubMed Web of Science ®Google Scholar
• ChuHLinZZhongLMcCallumRWHouXTreatment of high-frequency gastric electrical stimulation for gastroparesisJ Gastroenterol Hepatol20122761017102622128901
   PubMed Web of Science ®Google Scholar
• HeckertJSankineniAHughesWBHarbisonSParkmanHGastric electric stimulation for refractory gastroparesis: a prospective analysis of 151 patients at a single centerDig Dis Sci201661116817526280084
   PubMed Web of Science ®Google Scholar
• McCallumRWLinZForsterJRoeserKHouQSarosiekIGastric electrical stimulation improves outcomes of patients with gastroparesis for up to 10 yearsClin Gastroenterol Hepatol201194314319.e121185396
   PubMed Web of Science ®Google Scholar
• SarosiekIForsterJLinZCherrySSarosiekJMcCallumRThe addition of pyloroplasty as a new surgical approach to enhance effectiveness of gastric electrical stimulation therapy in patients with gastroparesisNeurogastroenterol Motil2013252e134e180
   PubMed Web of Science ®Google Scholar
• DavisBRSarosiekIBashashatiMAlvaradoBMcCallumRWThe long-term efficacy and safety of pyloroplasty combined with gastric electrical stimulation therapy in gastroparesisJ Gastrointest Surg201721222222727896652
   PubMed Web of Science ®Google Scholar
• ShadaALDunstCMPescarusRLaparoscopic pyloroplasty is a safe and effective first-line surgical therapy for refractory gastroparesisSurg Endosc20163041326133226293794
   PubMed Web of Science ®Google Scholar
• RodriguezJHHaskinsINStrongATPer oral endoscopic pyloromyotomy for refractory gastroparesis: initial results from a single institutionSurg Endosc201731125381538828567693
   PubMed Web of Science ®Google Scholar
• GonzalezJMBenezechAVittonVBarthetMG-POEM with antropyloromyotomy for the treatment of refractory gastroparesis: mid-term follow-up and factors predicting outcomeAliment Pharmacol Ther201746336437028504312
   PubMed Web of Science ®Google Scholar
• KhashabMANgamruengphongSCarr-LockeDGastric peroral endoscopic myotomy for refractory gastroparesis: results from the first multicenter study on endoscopic pyloromyotomy (with video)Gastrointest Endosc201785112312827354102
   PubMed Web of Science ®Google Scholar
• SnapeWJLinMSAgarwalNShawREEvaluation of the pylorus with concurrent intraluminal pressure and EndoFLIP in patients with nausea and vomitingNeurogastroenterol Motil201628575876426813266
   PubMed Web of Science ®Google Scholar
• OwyangCPhenotypic switching in diabetic gastroparesis: mechanism directs therapyGastroenterology201114141134113721875587
   PubMed Web of Science ®Google Scholar
• GonzalezJMLestelleVBenezechAGastric peroral endoscopic myotomy with antropyloromyotomy in the treatment of refractory gastroparesis: clinical experience with follow-up and scintigraphic evaluation (with video)Gastrointest Endosc201785113213927478028
   PubMed Web of Science ®Google Scholar